70 related articles for article (PubMed ID: 7786967)
21. Spatial and selective attention in the cerebral hemispheres in depression, mania, and schizophrenia.
David AS
Brain Cogn; 1993 Nov; 23(2):166-80. PubMed ID: 8292324
[TBL] [Abstract][Full Text] [Related]
22. Depression and cerebral dominance. A study of bilateral intracarotid amytal in eleven depressed patients.
Hommes OR; Panhuysen LH
Psychiatr Neurol Neurochir; 1970; 74(3):259-70. PubMed ID: 5518234
[No Abstract] [Full Text] [Related]
23. Effects of clozapine, fluphenazine, and placebo on reaction time measures of attention and sensory dominance in schizophrenia.
Zahn TP; Pickar D; Haier RJ
Schizophr Res; 1994 Sep; 13(2):133-44. PubMed ID: 7986770
[TBL] [Abstract][Full Text] [Related]
24. Brain activation mediates the association between structural abnormality and symptom severity in schizophrenia.
Weinstein S; Woodward TS; Ngan ET
Neuroimage; 2007 May; 36(1):188-93. PubMed ID: 17398119
[TBL] [Abstract][Full Text] [Related]
25. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
[TBL] [Abstract][Full Text] [Related]
26. The effect of illness duration on perceptual asymmetry in schizophrenia.
Carr V; Wale J; Dewis S; Stephan L
Schizophr Res; 1992 Sep; 7(3):211-6. PubMed ID: 1356424
[TBL] [Abstract][Full Text] [Related]
27. EEG asymmetry in schizophrenic patients before and during neuroleptic treatment.
Merrin EL; Fein G; Floyd TC; Yingling CD
Biol Psychiatry; 1986 May; 21(5-6):455-64. PubMed ID: 2870742
[TBL] [Abstract][Full Text] [Related]
28. Lateralized attentional deficits in drug-free and medicated schizophrenic patients.
Wigal SB; Swanson JM; Potkin SG
Neuropsychologia; 1997 Dec; 35(12):1519-25. PubMed ID: 9460721
[TBL] [Abstract][Full Text] [Related]
29. Selective anterior cingulate cortex deficit during conflict solution in schizophrenia: an event-related potential study.
Neuhaus AH; Koehler S; Opgen-Rhein C; Urbanek C; Hahn E; Dettling M
J Psychiatr Res; 2007 Oct; 41(8):635-44. PubMed ID: 16908030
[TBL] [Abstract][Full Text] [Related]
30. Depression in schizophrenia: I. Association with neuropsychological deficits.
Kohler C; Gur RC; Swanson CL; Petty R; Gur RE
Biol Psychiatry; 1998 Feb; 43(3):165-72. PubMed ID: 9494697
[TBL] [Abstract][Full Text] [Related]
31. Gray matter-changes and correlates of disease severity in schizophrenia: a statistical parametric mapping study.
Wilke M; Kaufmann C; Grabner A; Pütz B; Wetter TC; Auer DP
Neuroimage; 2001 May; 13(5):814-24. PubMed ID: 11304078
[TBL] [Abstract][Full Text] [Related]
32. Executive function in schizophrenia: what impact do antipsychotics have?
O'Grada C; Dinan T
Hum Psychopharmacol; 2007 Aug; 22(6):397-406. PubMed ID: 17579928
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
Rémillard S; Pourcher E; Cohen H
J Int Neuropsychol Soc; 2008 Jan; 14(1):110-8. PubMed ID: 18078537
[TBL] [Abstract][Full Text] [Related]
34. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
Semkovska M; Bédard MA; Stip E
Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
[TBL] [Abstract][Full Text] [Related]
35. Abnormal lateralization of motor activity during sleep in schizophrenia.
Lauerma H; Niskanen L; Lehtinen I; Holmström R
Schizophr Res; 1994 Dec; 14(1):65-71. PubMed ID: 7893623
[TBL] [Abstract][Full Text] [Related]
36. Neuroleptics reverse attention asymmetries in schizophrenic patients.
Tomer R; Flor-Henry P
Biol Psychiatry; 1989 Apr; 25(7):852-60. PubMed ID: 2566334
[TBL] [Abstract][Full Text] [Related]
37. Application of a multifractal analysis to study brain white matter abnormalities of schizophrenia on T2-weighted magnetic resonance imaging.
Takahashi T; Kosaka H; Murata T; Omori M; Narita K; Mitsuya H; Takahashi K; Kimura H; Wada Y
Psychiatry Res; 2009 Mar; 171(3):177-88. PubMed ID: 19217265
[TBL] [Abstract][Full Text] [Related]
38. Effects of neuroleptic medications on the cognition of patients with schizophrenia: a review of recent studies.
Goldberg TE; Weinberger DR
J Clin Psychiatry; 1996; 57 Suppl 9():62-5. PubMed ID: 8823353
[TBL] [Abstract][Full Text] [Related]
39. Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms.
Brazo P; Delamillieure P; Morello R; Halbecq I; Marié RM; Dollfus S
Psychiatry Res; 2005 Jan; 133(1):45-55. PubMed ID: 15698676
[TBL] [Abstract][Full Text] [Related]
40. Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology.
Wolkin A; Sanfilipo M; Angrist B; Duncan E; Wieland S; Wolf AP; Brodie JD; Cooper TB; Laska E; Rotrosen JP
Biol Psychiatry; 1994 Sep; 36(5):317-25. PubMed ID: 7993958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
